Scott Ackler
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
-
- Cell death mechanisms and regulation 8
- PI3K/AKT/mTOR signaling in cancer 1
- bioluminescence and chemiluminescence research 1
- Mitochondrial Function and Pathology 1
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Steven W. Elmore (5 shared papers)Anatol Oleksijew (6 shared papers)Saul H. Rosenberg (5 shared papers)Michael J. Mitten (5 shared papers)David J. Frost (5 shared papers)Christin Tse (4 shared papers)Stephen W. Fesik (4 shared papers)Kelly Foster (5 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Blood (1 paper)Clinical Cancer Research (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Scott Ackler
11 papers receiving 3.3k citations
Scott Ackler's Hit Papers
Peers
Comparison fields: 5 of 86
- Genetics 479
- Hematology 394
- Molecular Biology 1.7k
- Pathology and Forensic Medicine 255
- Computational Theory and Mathematics 236
Countries citing papers authored by Scott Ackler
This map shows the geographic impact of Scott Ackler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Ackler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Ackler more than expected).
Fields of papers citing papers by Scott Ackler
This network shows the impact of papers produced by Scott Ackler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Ackler. The network helps show where Scott Ackler may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Ackler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets Hit paper breakdown → | 2013 | 2531 |
| 2 | 2008 | 176 | |
| 3 | Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208 | 2013 | 167 |
| 4 | 2011 | 134 | |
| 5 | 2010 | 108 | |
| 6 | 2002 | 80 | |
| 7 | 2008 | 66 | |
| 8 | 2010 | 51 | |
| 9 | 2012 | 35 | |
| 10 | 2015 | 23 | |
| 11 | 2006 | 2 | |
| 12 | 2017 | 0 |
About Scott Ackler
Scott Ackler is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Genetics, Oncology and Nuclear Energy and Engineering, having authored 12 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (8 papers), Lymphoma Diagnosis and Treatment (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper), bioluminescence and chemiluminescence research (1 paper), Lung Cancer Research Studies (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Genetics (479 citations), Hematology (394 citations), Molecular Biology (1.7k citations), Pathology and Forensic Medicine (255 citations) and Computational Theory and Mathematics (236 citations). Scott Ackler has collaborated with scholars based in United States and Australia. Frequent co-authors include Steven W. Elmore, Anatol Oleksijew, Saul H. Rosenberg, Michael J. Mitten, David J. Frost, Christin Tse, Stephen W. Fesik, Kelly Foster, Marion L. Refici and Stephen K. Tahir. Their work appears in journals such as Molecular Cancer Therapeutics, Blood, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.